One of the most promising—and pressing—areas of research has to do with the effects of medical marijuana on people with diabetes. Millions of people suffering from the disease are looking for relief from both the symptoms and the high costs healthcare associated with treating the disease.
Both types are still difficult disorders to control physically as well as emotionally. There are some medications and exercise and diet changes can help reverse the symptoms of Type 2 diabetes, but there is no cure for Type 1 which is very cumbersome to control.
Yet in the past decades, there has been a rapid acceleration of new research and technology to help to make the lives of people with diabetes easier to manage.
Restoring the function of pancreatic beta cells would represent a leap forward in treating diabetes, potentially allowing insulin-dependent patients to wean themselves off frequent blood sugar monitoring and injections. But work has been hampered by difficulties in developing differentiated cells that can respond to the body’s need for glucose modulation and protecting these from the autoimmune response that is the hallmark of type 1 diabetes.
Here’s the tough question: How will we know how well the system works? Diabetes software doesn’t exactly have the best track record when it comes to accuracy. A 2015 study found that among smartphone apps for calculating insulin doses, two-thirds of the apps risked giving incorrect results, often substantially so. So far, the most developed diabetes A.I. is incorporated into devices, not stand-alone, and we might hope that device-makers have more expertise than potentially fly-by-night app developers.
Bariatric surgery has been shown to relieve Type II diabetes. Scientists at Glyscend are developing a drug that could mimic the effect—but with no surgery required.
GOOGLE'S LIFE SCIENCES division has its first big mission: developing new ways to treat and manage diabetes. But in a sign that the company is serious about making real progress, it's not diving into diabetes research alone. It is working with French pharmaceutical giant Sanofi, one of the world's largest pharmaceutical companies.
We are closer to understanding the genetic contribution and environmental factors of type 1 diabetes. But when something develops over several years, like diabetes, it's much more difficult to determine the cause.
This is an exciting time in diabetes research, with the SDP resulting in potential therapies that could transform millions of lives and improve the fiscal health of our nation. We cannot afford to stop now.
Researchers at the Mount Sinai Diabetes Center have already developed an artificial pancreas. Next, a drug that could regenerate pancreatic cells in the body.
Can synthetic biology finally cure the autoimmune disease?
The Diabetes Action Research and Education Foundation (Diabetes Action), a non-profit 501(c)3 organization founded in 1990, is committed to the prevention and treatment of diabetes and to the funding of innovative, promising research aimed at finding a cure for diabetes and diabetes related complications.
One of the research efforts supported by the Diabetes National Research Group is to identify antigens. Antigens are substances capable of inducing an immune response that might be involved in the onset of diabetes. T cells, immune cells that destroy invading organisms and help other cells make antibodies that cause diabetes, are transferred into recipient experimental models.
We aim to achieve benefits for people with diabetes, or at risk of developing diabetes, through excellence in clinical research.
Diabetesgenes.org aims to provide information for patients and professionals on research and clinical care in genetic types of diabetes.
Joslin Diabetes Center — dedicated to conquering diabetes in all of its forms — is the global leader in diabetes research, care and education. Joslin research is at the forefront of discovery aimed at preventing and curing diabetes.
The Juvenile Diabetes Research Foundation is here to find a cure for diabetes and to help you deal with diabetes day-to-day.
Life has improved for people with diabetes, and research continues to offer hope.
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is committed to sharing the latest in health information. Visit the websites below to learn more about current diabetes research or to participate in a clinical trial.
Sansum Diabetes Research Institute is a research center devoted to the prevention, treatment and cure of diabetes.
The SBDR is an international scientific society dedicated to the advancement of biomedical research to secure remission of diabetes and an improvement in patients' healthcare.
The Aoki Diabetes Research Institute (ADRI) in Sacramento, California is a non-profit organization dedicated to research in the areas of diabetes and metabolism.
The BBDC was established in 1978 as an extra-departmental unit of the Faculty of Medicine, University of Toronto with the primary objective of advancing diabetes research, education, and patient care.
The Boston Area Diabetes Endocrinology Research Center (BADERC) is a consortium of laboratory-based and clinical investigators whose efforts are directed toward addressing many of the major research questions bearing on the etiology, pathogenesis, treatment and cure of type 1 and type 2 diabetes, and their associated microvascular and atherosclerotic complications.
The Diabetes Education and Research Center is a non-profit organization serving the needs of people living in Philadelphia, PA and surrounding communities.
The University of Chicago Diabetes Research and Training Center (DRTC) provides resources for the support and coordination of the research and training activities in diabetes and related metabolic and endocrine disorders.
Cyclin-dependent kinase 4 is a preclinical target for diet-induced obesity
Featured Article: Cyclin-dependent kinase 4 is a preclinical target for diet-induced obesity
JCI Insight (Sept. 6, 2018)
The Einstein-Mount Sinai Diabetes Research Center (ES-DRC) comprises a vibrant, extensive, diverse, well-funded and highly productive program that provides the foundation for high-quality and cutting-edge research in diabetes and related studies in obesity, metabolism and endocrinology...
IDOM enhances and supports research aimed at understanding the genetic, biochemical, molecular, environmental, and behavioral mechanisms underlying diabetes and obesity.
The Michigan Diabetes Research Center (MDRC) is a multidisciplinary unit of the University of Michigan funded by the National Institute of Diabetes and Digestive and Kidney Diseases/National Institute of Health.
The Vanderbilt Diabetes Research and Training Center (DRTC) is a NIH-sponsored Diabetes Center that facilitates the discovery, application, and translation of scientific knowledge to improve the care of patients with diabetes.